Compound ID | 324
BC-2901
Class: Beta-lactam
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus |
| Institute where first reported: | Sandoz GmbH, Austria |
| Year first mentioned: | 2005 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.